Shares of SINO BIOPHARMACEUT HKD0.025 (NASDAQ:SBMFF) have been given an average broker rating score of 4.00 (Sell) from the one analysts that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a sell recommendation.

Zacks has also given SINO BIOPHARMACEUT HKD0.025 an industry rank of 110 out of 265 based on the ratings given to its competitors.

Separately, Zacks Investment Research upgraded SINO BIOPHARMACEUT HKD0.025 from a “hold” rating to a “buy” rating and set a $1.00 target price for the company in a report on Thursday, August 10th.

Shares of SINO BIOPHARMACEUT HKD0.025 (NASDAQ SBMFF) traded up 1.02% during mid-day trading on Friday, reaching $0.99. 500 shares of the company’s stock were exchanged. The firm has a market capitalization of $7.34 billion and a P/E ratio of 26.05. SINO BIOPHARMACEUT HKD0.025 has a one year low of $0.63 and a one year high of $0.99. The stock has a 50-day moving average of $0.88 and a 200 day moving average of $0.81.

WARNING: “Zacks: SINO BIOPHARMACEUT HKD0.025 (SBMFF) Given Average Recommendation of “Sell” by Brokerages” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this story can be accessed at

Get a free copy of the Zacks research report on SINO BIOPHARMACEUT HKD0.025 (SBMFF)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Stock Ratings for SINO BIOPHARMACEUT HKD0.025 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SINO BIOPHARMACEUT HKD0.025 and related stocks with our FREE daily email newsletter.